CX3CR1 and systemic sclerosis: Relatively high heterogeneity in the expression of CX3CR1 via NK cells was observed in SSc patients, and in addition, a positive alliance with the anti‐topoisomerase1 antibodies and pulmonary fibrosis was also conducted.10